[Toxicity and antineoplastic activity of a new thio-TEPA analog].
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005609:Free Radicals; D007942:Leukemia, Experimental / Q000188:drug therapy; D008113:Liver Neoplasms; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy; D013852:Thiotepa / Q000627:therapeutic use* / Q000633:toxicity
D004273:DNA, Neoplasm; D005609:Free Radicals; D013852:Thiotepa
Toksichnost' i protivoopukholevaia aktivnost' novogo analoga tioTEFa.